Female heart health: Top medical groups issue Female Life Stage framework

For the first time, the new framework, dubbed the “Female Life Stage framework,” emphasizes the impact of hormonal changes and female life stages on lifetime cardiovascular risk.

Firstly, the framework outlines up to five distinct life stages defined by hormonal changes associated with changes to the female reproductive system:

1. Perimenarche, when the first menstrual period occurs, approximate between 8 to 15 years of age
2. Ovarian cycling, when regular menstrual cycles occur and pregnancy is possible, approximate between the ages of 15 and 44
3. Perimenopause, the period of transition into menopause, approximately between the ages of 45 to 51
4. Postmenopause, the period after menopause, approximately at age 51 years or older
5. Pregnancy, which can occur at various ages after the start of the menstrual cycle.

“A Female-Specific Life Course Approach to the Prevention and Management of Cardiovascular Disease” and “Consensus Guidance for the Female-Specific Prevention and Management of Cardiovascular Disease” outline how these various stages and the hormonal changes that accompany them can uniquely shape cardiovascular risk, as well as prevention strategies that take these aspects into account.

“The central message [outlined in this new framework] is that a woman’s heart health is shaped across her entire life, and each biological transition offers an opportunity to preserve function and prevent disease,” Lala-Trindade told MNT.

“Menstrual history, pregnancy history, and the menopause transition belong in our cardiovascular assessment. These are clinically meaningful parts of a woman’s health story that should inform how we care for her,” she emphasized.

Suppogu added that “historically, care [for women] has often been fragmented, with reproductive health, hormonal changes, and cardiovascular health considered separately.”

“This framework brings these elements together and highlights how hormonal transitions throughout a woman’s life can influence cardiovascular risk and long-term outcomes,” she told us.

“I particularly appreciate how the framework organizes care around key life stages, including premenarche, menarche, the reproductive years, perimenopause, and postmenopause. It also emphasizes that certain cardiovascular risk factors are unique to women, disproportionately affect women, or influence women differently because of hormonal changes and other sex-specific factors. Recognizing these differences is essential to identifying risk earlier, improving prevention, and providing more individualized cardiovascular care.”

– Nissi Suppogu, MD

The framework acknowledges that heart health is tied to both hormonal changes and psychosocial impact — which includes experiences of depression and anxiety — over the life course.

It notes that period patterns, such as experiencing heavy or irregular bleeding, can be an early marker of conditions linked to heightened cardiovascular risk, such as polyendocrine metabolic ovarian syndrome (PMOS), and that perimenopause can bring changes in cholesterol levels and other metabolic markers, which, in turn, can affect heart health.

For this reason, the guidance also advises that identifying early signs of cardiovascular problems at perimenopause is key to addressing them and mitigating the risk.

In terms of the impact of psychosocial factors on heart health, the medical societies note that issues such as anxiety, depression, and eating disorders can heighten cardiovascular risk.

Finally, the consolidated guidance emphasizes the importance of tracking any and all health changes during pregnancy, which is a key time to unmask cardiovascular risk, and of providing cardiovascular-specific care at the postpartum stage.

Speaking to MNT, Lala-Trindade commented: “I particularly welcome the integration of hormonal, psychosocial, and cardiovascular health. In practice, women experience these together.”

“Sleep disruption, emotional stress, metabolic changes, and hormonal transitions interact, and our care should reflect that interconnectedness,” she told us, adding that “perimenopause is an especially valuable moment to reassess cardiovascular health and intervene early.”

“We should help women understand that this transition offers an opportunity to influence their future health,” said Lala-Trindade.

“As a heart failure cardiologist, I see this through the lens of preserving heart function. The goal is to give women more years with the energy, capacity, and well-being to live the lives they want.” 

– Anuradha Lala-Trindade, MD

“What makes this framework distinctive is its comprehensive, lifespan-based approach,” Suppogu reiterated. “Previous guidelines have addressed important aspects of women’s cardiovascular health, but many have focused on specific conditions, risk factors, or stages of life in isolation.”

“As a result, clinicians have not always had a unified framework for understanding how a woman’s cardiovascular health evolves from childhood through menopause and beyond,” she explained.

“This guidance connects those different stages and demonstrates how clinical presentations, reproductive milestones, and hormonal transitions may influence cardiovascular health later in life. It encourages clinicians to look beyond a woman’s immediate symptoms or traditional cardiovascular risk factors and consider her broader health history, including reproductive and hormonal factors. That more integrated perspective is an important step toward earlier recognition of risk and more effective, personalized prevention.”

– Nissi Suppogu, MD

“We have had important guidance on pregnancy-related cardiovascular risk, menopause, and cardiovascular prevention in women. What distinguishes this effort is the shared structure across four societies, beginning in childhood and connecting care across a woman’s life,” added Lala-Trindade.

“It brings recommendations from different specialties into a common framework organized around female biological transitions,” she noted.

“For me, its greatest promise is continuity,” Lala-Trindade told MNT, offering examples of what this means. For instance, “a history of preeclampsia should remain clinically relevant long after the postpartum visit,” she emphasized.

Similarly, “menstrual and metabolic concerns identified in adolescence should inform adult care,” she pointed out. “Women should be able to move between pediatricians, obstetrician-gynecologists, primary care clinicians, and cardiologists with their health story intact.”

Lala-Trindade also commended “the accompanying proposal for comprehensive women’s cardiovascular centers, [which] recognizes that delivering this care requires infrastructure: interdisciplinary teams, education, research, and community partnerships.”

While both cardiologists were heartened by the consolidated framework and guidance, they nevertheless highlighted some lingering concerns.

“My biggest question is how we make this actionable in everyday practice,” said Lala-Trindade. “The publications appropriately recognize implementation and research gaps.”

“The next step is to define who is responsible for follow-up, how information moves between specialties, and how clinicians are given the time and resources to act. Shared responsibility needs clear accountability,” she pointed out.

Lala-Trindade emphasized that time will tell whether or not the new guidance is also implemented successfully. “I would […] want success measured by outcomes that matter to women: physical function, symptom burden, quality of life, and access to care, alongside cardiovascular events,” she told us.

“Ultimately, the value of this framework will be demonstrated by how consistently it changes the care a woman receives,” she pointed out.

Similarly, Suppogu told us that: “An important next step will be translating this framework into routine clinical practice. We need to ensure that clinicians have the education, screening tools, and practical guidance to recognize female-specific cardiovascular risk factors and incorporate them into prevention and treatment decisions.”

“We also need further research to understand how these risks vary among diverse populations and which interventions are most effective at different life stages,” she added.

“Ultimately, the framework provides a valuable foundation, and continued research and implementation will help us determine how best to use it to improve cardiovascular outcomes for women,” she concluded.